1-20 of 36
Michael Slade
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Convenience Versus Continuity: A Natural History Study of a Newly Opened Plasma Cell Disorders Clinic in an Underserved Community and Desire for Transfer of Care Among Previously Diagnosed Patients

Michael Slade, Ravi Vij, Keith Stockerl-Goldstein, Mark A. Schroeder, Angela Vickroy, Margaret Kavanaugh, Carmen Wilson, Mark Fiala
Journal: Blood
Blood (2024) 144 (Supplement 1): 3653.
https://doi.org/10.1182/blood-2024-203469
Published: 2024
Journal Articles

Real-World Experience with Elotuzumab, Pomalidomide, and Dexamethasone As Second or Third-Line Therapy in Relapsed and Refractory Multiple Myeloma

Akhil Kesaraju, Alexa Loncharich, Keith Stockerl-Goldstein, Mark A. Schroeder, Angela Vickroy, Ravi Vij, Michael Slade
Journal: Blood
Blood (2024) 144 (Supplement 1): 6936.
https://doi.org/10.1182/blood-2024-208241
Published: 2024
Journal Articles

Single-Cell Analysis Reveals Depletion of Antigen-Presenting Cell (APC) and IFN-Stimulated CD4 T Cell Populations in High-Risk Newly Diagnosed Multiple Myeloma Patients

Junia Vieira, Alison S Park, David Melnekoff, Tarek H. Mouhieddine, Alessia D'anna, Adolfo Aleman, Meghana Ram, Katerina Kappes, Mark Hamilton, George Mulligan, Arun P Wiita, Ajai Chari, Thomas Martin, Michael Slade, Li Ding, Ravi Vij, Brian Brown, Benjamin Tycko, Rena Feinman, David S. Siegel, Sundar Jagannath, Samir Parekh, Alessandro Lagana
Journal: Blood
Blood (2024) 144 (Supplement 1): 4654.
https://doi.org/10.1182/blood-2024-208308
Published: 2024
Journal Articles

A Phase I/II Study of AZD0305, a Novel Antibody-Drug Conjugate (ADC) Targeting GPRC5D, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Sueh-Li Lim, Bradley Augustson, Hira S Mian, Edward A. Stadtmauer, Shinsuke Iida, Michael Slade, Saswati Hazra, Kamal Chamoun, Patricia Cheung, Jamal Saeh, Nina Shah, Amrita Y Krishnan
Journal: Blood
Blood (2024) 144 (Supplement 1): 2000.2.
https://doi.org/10.1182/blood-2024-207816
Published: 2024
Journal Articles

Clearance of Circulating Multiple Myeloma Cells to Assess Early Response to Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma

Binod Dhakal, Michael Slade, Ravi Narra, Mostafa E. Mohamed, Othman S. Akhtar, Hima Bansal, Maria Jose Acevedo-Calado, Oren Pasvolsky, Mahmoud R. Gaballa, Melody R. Becnel, Donna M. Weber, Krina K. Patel, Sheeba K. Thomas, J Christine Ye, Frank Kuhr, Bamboo Dong, Shemeeakah Powell, Thai Bui, Meera Mohan, Marcelo C. Pasquini, Anita D'Souza, Halyna Knysh, Robert Z. Orlowski, Maher Albitar, Hans C. Lee
Journal: Blood
Blood (2024) 144 (Supplement 1): 4687.
https://doi.org/10.1182/blood-2024-209181
Published: 2024
Journal Articles

Clearance of Leukemia Associated Mutations (LAMs) after Induction Therapy Is Associated with Favorable Outcomes in Intermediate Risk Acute Myeloid Leukemia: Interim Results of a Multicenter, Prospective Phase II Trial

Meagan Jacoby, David H Spencer, Geoffrey L. Uy, Feng Gao, Tasha Burton, Sharon E Heath, Feiyu Du, Shelly O'Laughlin, Robert Fulton, Zeina A. Al-Mansour, Christopher R. Cogle, Eric J Huselton, John F. DiPersio, Peter Westervelt, Mark A. Schroeder, Armin Ghobadi, Iskra Pusic, Keith Stockerl-Goldstein, Brad S. Kahl, Amanda F. Cashen, Matt Christopher, Nathan Singh, Ravi Vij, Zachary D. Crees, Ryan B. Day, Todd A Fehniger, Karolyn Oetjen, Dilan A. Patel, Miriam Y Kim, Michael Slade, Daniel C. Link, Matthew J. Walter, Camille N. Abboud, Ramzi Abboud, Timothy J Ley
Journal: Blood
Blood (2024) 144 (Supplement 1): 224.
https://doi.org/10.1182/blood-2024-201694
Published: 2024
Journal Articles

Evaluating Diagnostic Performance of Light Chain Dimerization By Mass Spectrometry to Distinguish between AL Amyloidosis and Monoclonal Gammopathy of Undetermined Significance

Alexa Loncharich, Mark Fiala, Julie Fortier, Keith Stockerl-Goldstein, Ravi Vij, Mark A. Schroeder, Mark Zaydman, Michael Slade, Mariya Liyasova
Journal: Blood
Blood (2024) 144 (Supplement 1): 1921.
https://doi.org/10.1182/blood-2024-211395
Published: 2024
Journal Articles

Impact of Absolute Lymphocyte Counts (ALC) on Outcomes Following Bispecific Antibody Therapy in Patients with Relapsed/Refractory Multiple Myeloma Patients: A Single Center Real-World Experience

Yash Shah, Mark Fiala, Keith Stockerl-Goldstein, Mark A. Schroeder, Ravi Vij, Zachary D. Crees, Michael Slade
Journal: Blood
Blood (2024) 144 (Supplement 1): 3792.1.
https://doi.org/10.1182/blood-2024-209293
Published: 2024
Journal Articles

Enhancing MHC-Independent T Cell Receptors Using Rational Protein Engineering

Jufang Chang, Jack Landmann, Yangdon Tenzin, John Warrington, Mehmet Emrah Selli, Tien-Ching Chang, Michael Slade, Deepesh Gupta, Nathan Singh
Journal: Blood
Blood (2023) 142 (Supplement 1): 354.
https://doi.org/10.1182/blood-2023-182154
Published: 2023
Journal Articles

Measurable Residual Disease Status By Clonotypic Mass Spectrometry with Easym Assay Predicts Outcomes Following Autologous Hematopoietic Cell Transplant in Multiple Myeloma

Michael Slade, Abir Khaled, Mark Fiala, Zac McDonald, Mariya Liyasova, Julie Fortier, Mark Zaydman, Sarah Kelley, Zachary David Crees, Mark A. Schroeder, Keith Stockerl-Goldstein, Liqiang Yang, Ravi Vij
Journal: Blood
Blood (2023) 142 (Supplement 1): 3354.
https://doi.org/10.1182/blood-2023-172440
Published: 2023
Journal Articles

Patient Recorded Outcomes from a Randomized, Controlled Phase 2 Trial of E-Selectin Inhibition with Uproleselan Vs Placebo to Reduce GI Toxicity during Melphalan-Conditioned Autologous Hematopoietic Cell Transplantation for Multiple Myeloma

Meaghan Ryan, Zachary David Crees, Michael Slade, Mark A. Schroeder, Ravi Vij, Geoffrey L Uy, Keith Stockerl-Goldstein
Journal: Blood
Blood (2023) 142 (Supplement 1): 2217.
https://doi.org/10.1182/blood-2023-179604
Published: 2023
Journal Articles

Novel Assay for Quantification of Free Light Chain (FLC) Dimers in Serum of Patients with Plasma Cell Dyscrasias

Mariya Liyasova, Michael Slade, Julie Fortier, Ravi Vij, Mark Fiala, Liqiang Yang, Bin Ma
Journal: Blood
Blood (2023) 142 (Supplement 1): 2292.
https://doi.org/10.1182/blood-2023-186583
Published: 2023
Journal Articles

Duvelisib for Cytokine Release Syndrome Prophylaxis during CD19-Targeted CAR T Cell Therapy

Michael Slade, Michael P. Rettig, Zachary David Crees, Neha Mehta-Shah, Todd A Fehniger, Amanda F Cashen, Iskra Pusic, Geoffrey L Uy, Peter Westervelt, John DiPersio, Armin Ghobadi
Journal: Blood
Blood (2023) 142 (Supplement 1): 3470.
https://doi.org/10.1182/blood-2023-172439
Published: 2023
Journal Articles

Costimulatory domains direct distinct fates of CAR-driven T-cell dysfunction

Mehmet Emrah Selli, Jack H. Landmann, Marina Terekhova, John Lattin, Amanda Heard, Yu-Sung Hsu, Tien-Ching Chang, Jufang Chang, John Warrington, Helen Ha, Natalie Kingston, Graham Hogg, Michael Slade, Melissa M. Berrien-Elliott, Mark Foster, Samantha Kersting-Schadek, Agata Gruszczynska, David DeNardo, Todd A. Fehniger, Maxim Artyomov, Nathan Singh
Journal: Blood
Blood (2023) 141 (26): 3153–3165.
https://doi.org/10.1182/blood.2023020100
Published: 2023
Includes: Supplemental data
Journal Articles

The role of allogeneic transplant for adult Ph + ALL in CR1 with complete molecular remission: a retrospective analysis

CME Clinical Trials & Observations
Armin Ghobadi, Michael Slade, Hagop Kantarjian, Julio Alvarenga, Ibrahim Aldoss, Kahee A. Mohammed, Elias Jabbour, Rawan Faramand, Bijal Shah, Frederick Locke, Warren Fingrut, Jae H. Park, Nicholas J. Short, Feng Gao, Geoffrey L. Uy, Peter Westervelt, John F. DiPersio, Richard E. Champlin, Monzr M. Al Malki, Farhad Ravandi, Partow Kebriaei
Journal: Blood
Blood (2022) 140 (20): 2101–2112.
https://doi.org/10.1182/blood.2022016194
Published: 2022
Includes: Supplemental data
Journal Articles

The Impact of Tocilizumab Treatment for Cytokine Release Syndrome on the Incidence of Blood Stream Infections after Peripheral Blood Haploidentical Hematopoietic Cell Transplantation

Elisa De Togni, Fei Wan, Michael Slade, Ramzi Abboud
Journal: Blood
Blood (2021) 138 (Supplement 1): 1800.
https://doi.org/10.1182/blood-2021-147103
Published: 2021
Journal Articles

Impact of Donor Age and Relationship on Outcomes of Peripheral Blood Haploidentical Hematopoietic Cell Transplantation

Aaron Pruitt, Feng Gao, Elisa De Togni, Aaron Singareddy, Hunter Cochran, Sonia Godbole, Michael Slade, Ramzi Abboud
Journal: Blood
Blood (2021) 138 (Supplement 1): 2924.
https://doi.org/10.1182/blood-2021-149718
Published: 2021
Journal Articles

Comparison of Deep Whole Exome Versus Targeted Gene Sequencing for Assessment of Persistent Molecular Disease in Acute Myeloid Leukemia Samples

Michael Slade, MDMS, Michelle O'Laughlin, Robert S Fulton, Eric J. Duncavage, MD, Timothy J Ley, MD, Meagan A. Jacoby, MD, David H Spencer, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-133279
Published: 2020
Journal Articles

HLA Class II Epitope Mismatch Influences Relapse and Engraftment in Peripheral Blood Haploidentical Hematopoietic Cell Transplantation

Joseph Rimando, MD, Michael Slade, MD MS, Feng Gao, PhD, Rizwan Romee, MD, Chang Liu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4634.
https://doi.org/10.1182/blood-2018-99-112494
Published: 2018
Journal Articles

Tocilizumab Is Safe after T-Cell Replete Peripheral Blood Haploidentical Donor Transplantation

Ramzi Abboud, MD BS, Michael Slade, MDMS, Kathryn Trinkaus, PhD, Camille N. Abboud, MD, John F DiPersio, MD PhD, Todd A. Fehniger, MDPhD, Geoffrey L. Uy, MD, Peter Westervelt, MDPhD, Ravi Vij, MDMBA, Mark A. Schroeder, MD, Iskra Pusic, MD, Armin Ghobadi, MD, Rizwan Romee, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3213.
https://doi.org/10.1182/blood.V130.Suppl_1.3213.3213
Published: 2017